Different host defences are required to protect mice from primary systemic vs pulmonary infection with the facultative intracellular bacterial pathogen, Francisella tularensis LVS
- PMID: 11855943
- DOI: 10.1006/mpat.2001.0489
Different host defences are required to protect mice from primary systemic vs pulmonary infection with the facultative intracellular bacterial pathogen, Francisella tularensis LVS
Abstract
Francisella tularensis is a zoonotic, facultative intracellular bacterial pathogen capable of initiating infection, tularemia, via multiple routes including dermal micro-abrasions and inhalation. Mouse models of systemically-initiated infection with F. tularensis LVS have been used extensively to reveal potential host defence mechanisms against the pathogen. Such studies have demonstrated the critical need for neutrophils and interferon-gamma (IFN-gamma) to combat the early stages of primary experimental tularaemia initiated by systemic routes. Surprisingly, however, the present study shows that these defences appear not to combat early pulmonary tularaemia initiated by inhalation of the pathogen into the lower airways. The results imply that the effectiveness of particular anti-bacterial host defences vary with invasion site. Thus, it is impossible to predict effective host defence mechanisms against inhalation-initiated tularaemia from current knowledge of anti- Francisella defences that have been shown to combat systemically-initiated infection.
Copyright 2002 Academic Press.
Similar articles
-
Aerosol-, but not intradermal-immunization with the live vaccine strain of Francisella tularensis protects mice against subsequent aerosol challenge with a highly virulent type A strain of the pathogen by an alphabeta T cell- and interferon gamma- dependent mechanism.Vaccine. 2005 Mar 31;23(19):2477-85. doi: 10.1016/j.vaccine.2004.10.034. Vaccine. 2005. PMID: 15752834
-
Mouse model of oral infection with virulent type A Francisella tularensis.Infect Immun. 2007 Apr;75(4):1651-60. doi: 10.1128/IAI.01834-06. Epub 2007 Jan 22. Infect Immun. 2007. PMID: 17242058 Free PMC article.
-
Early activation of NK cells after lung infection with the intracellular bacterium, Francisella tularensis LVS.Cell Immunol. 2004 Nov-Dec;232(1-2):75-85. doi: 10.1016/j.cellimm.2005.02.001. Epub 2005 Mar 24. Cell Immunol. 2004. PMID: 15922718
-
Tularaemia: clinical aspects in Europe.Lancet Infect Dis. 2016 Jan;16(1):113-124. doi: 10.1016/S1473-3099(15)00355-2. Lancet Infect Dis. 2016. PMID: 26738841 Review.
-
Neutrophils: potential therapeutic targets in tularemia?Front Cell Infect Microbiol. 2013 Dec 27;3:109. doi: 10.3389/fcimb.2013.00109. eCollection 2013. Front Cell Infect Microbiol. 2013. PMID: 24409419 Free PMC article. Review.
Cited by
-
Francisella tularensis: taxonomy, genetics, and Immunopathogenesis of a potential agent of biowarfare.Annu Rev Microbiol. 2006;60:167-85. doi: 10.1146/annurev.micro.60.080805.142126. Annu Rev Microbiol. 2006. PMID: 16704343 Free PMC article. Review.
-
Host-pathogen interactions and immune evasion strategies in Francisella tularensis pathogenicity.Infect Drug Resist. 2014 Sep 18;7:239-51. doi: 10.2147/IDR.S53700. eCollection 2014. Infect Drug Resist. 2014. PMID: 25258544 Free PMC article. Review.
-
Phenotypic Characterization of a Novel Virulence-Factor Deletion Strain of Burkholderia mallei That Provides Partial Protection against Inhalational Glanders in Mice.Front Cell Infect Microbiol. 2016 Feb 26;6:21. doi: 10.3389/fcimb.2016.00021. eCollection 2016. Front Cell Infect Microbiol. 2016. PMID: 26955620 Free PMC article.
-
Genome-wide RNAi screen in IFN-γ-treated human macrophages identifies genes mediating resistance to the intracellular pathogen Francisella tularensis.PLoS One. 2012;7(2):e31752. doi: 10.1371/journal.pone.0031752. Epub 2012 Feb 16. PLoS One. 2012. PMID: 22359626 Free PMC article.
-
A Bioluminescent Francisella tularensis SCHU S4 Strain Enables Noninvasive Tracking of Bacterial Dissemination and the Evaluation of Antibiotics in an Inhalational Mouse Model of Tularemia.Antimicrob Agents Chemother. 2016 Nov 21;60(12):7206-7215. doi: 10.1128/AAC.01586-16. Print 2016 Dec. Antimicrob Agents Chemother. 2016. PMID: 27671061 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources